Arkuda Therapeutics

Developer of therapeutic solutions for neurological disorders

placeWatertown, Massachusetts, United States calendar_todayFounded 2018 groups28 employees language arkudatx.com

Registered entities

Innovation

9 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 174 times.

YearFilings
20191
20203
20214
20224
20235
20242

Investor mix

8 investors on record; lead investors include Pfizer, Atlas Venture, Cormorant Asset Management, Pivotal bioVenture Partners China.

Investor typeCountShare
Venture capital450%
Other / undisclosed450%
Coming soon